Antihypertensive treatment, myocardial infarction, and nocturnal myocardial ischaemia
1Division of Cardiology, Toronto General Hospital, Canada.
Abstract:
Patients with critical coronary stenoses or hypertrophied ventricles have impaired coronary vasodilator reserve and are at greatest risk of myocardial ischaemia or infarction if subendocardial perfusion pressure falls below the lower threshold of bloodflow autoregulation. During sleep, antihypertensive treatment may cause coronary artery perfusion pressure to fall below these limits in such patients. Unrecognised nocturnal hypotension may be one reason why treatment has not diminished the risk of myocardial infarction in patients with hypertension.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Related Concept Videos
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Myocarditis III: Medical Management
Acute Coronary Syndrome IV: Interprofessional Care
Angina II: Classification
Angina IV: Management
Angina V: Nursing Management
